Adjunctive glucocorticoids may reduce mortality among patients with severe community-acquired pneumonia (CAP) in ...

The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory ...

Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...

BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope; an additional FDA request for limited technical ...

A new study found that inhaling cannabis on a daily basis is linked to a higher risk of developing asthma and chronic obstructive pulmonary disease (COPD). The corresponding study was published in the ...

Nebulizers and automatic cars have something in common. They are both designed to facilitate the smooth operation of something essential. A 2022 article in the Wall Street Journal indicated that only ...

Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.

COPD Risk Confirmed: Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease. Hypertension Warning: A modest increase in high blood pressure was ...

Ohtuvayre (ensifentrine) is a prescription drug used to treat chronic obstructive pulmonary disease (COPD) in adults. Ohtuvayre comes as a liquid suspension for use with a nebulizer. To learn more ...

Mesh nebulizers have more frequent drug side effects and may cause a higher increase in heart rate than compressor nebulizers in pediatric patients with asthma. Pediatric patients with asthma using ...